Insider · CIK 0001637299

TRV GP III, LLC

CIK 0001637299 Name as filed on the most recent filing

Filed as TRV GP III, LLC (14)

36 transaction lines · from 14 filings · filed 2016-11-16 to 2023-02-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-02-01 S, Open-market sale Voyager Therapeutics, Inc.VYGR 1,198,943, disposed Open Form 4 filing 0000899243-23-003161
2023-01-31 S, Open-market sale Voyager Therapeutics, Inc.VYGR 1,711,250, disposed Open Form 4 filing 0000899243-23-003161
2023-01-30 S, Open-market sale Voyager Therapeutics, Inc.VYGR 677,250, disposed Open Form 4 filing 0000899243-23-003161
2023-01-27 S, Open-market sale Voyager Therapeutics, Inc.VYGR 451,000, disposed Open Form 4 filing 0000899243-23-003044
2023-01-25 S, Open-market sale Voyager Therapeutics, Inc.VYGR 461,000, disposed Open Form 4 filing 0000899243-23-002770
2023-01-24 S, Open-market sale Voyager Therapeutics, Inc.VYGR 927,000, disposed Open Form 4 filing 0000899243-23-002770
2023-01-23 S, Open-market sale Voyager Therapeutics, Inc.VYGR 498,300, disposed Open Form 4 filing 0000899243-23-002483
2023-01-20 S, Open-market sale Voyager Therapeutics, Inc.VYGR 915,000, disposed Open Form 4 filing 0000899243-23-002483
2022-08-25 S, Open-market sale Voyager Therapeutics, Inc.VYGR 1,244,000, disposed Open Form 4 filing 0000899243-22-029856
2022-08-24 S, Open-market sale Voyager Therapeutics, Inc.VYGR 913,329, disposed Open Form 4 filing 0000899243-22-029856
2022-08-16 S, Open-market sale Voyager Therapeutics, Inc.VYGR 775,874, disposed Open Form 4 filing 0000899243-22-029151
2022-08-15 S, Open-market sale Voyager Therapeutics, Inc.VYGR 820,280, disposed Open Form 4 filing 0000899243-22-028793
2022-08-12 S, Open-market sale Voyager Therapeutics, Inc.VYGR 2,129,803, disposed Open Form 4 filing 0000899243-22-028793
2022-06-08 S, Open-market sale Revolution Medicines, Inc.RVMD 8,502,995, disposed Open Form 4 filing 0000899243-22-022013
2021-11-12 S, Open-market sale Jounce Therapeutics, Inc.JNCE 15,922,000, disposed Open Form 4 filing 0000899243-21-044916
2021-01-14 S, Open-market sale Relay Therapeutics, Inc.RLAY 80,577,054, disposed Open Form 4 filing 0000899243-21-002117
2021-01-13 S, Open-market sale Relay Therapeutics, Inc.RLAY 10 lines 86,555,658, disposed Open Form 4 filing 0000899243-21-002117
2021-01-12 S, Open-market sale Relay Therapeutics, Inc.RLAY 60,000,000, disposed Open Form 4 filing 0000899243-21-002117
2019-07-22 P, Open-market purchase Fulcrum Therapeutics, Inc.FULC 1,300,000, acquired Open Form 4 filing 0000899243-19-020026
2018-01-03 S, Open-market sale MyoKardia IncMYOK 34,285,774, disposed Open Form 4 filing 0000899243-18-000584
2017-03-02 S, Open-market sale Global Blood Therapeutics, Inc.GBT 5 lines 52,245,476, disposed Open Form 4 filing 0000899243-17-006623
2016-11-14 S, Open-market sale Global Blood Therapeutics, Inc.GBT 2 lines 38,720,000, disposed Open Form 4 filing 0000899243-16-033679

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. TRV GP III, LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001637299

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.